BioSpace News Archive

Drug Development

Cancer Prevention Pharmaceuticals (CPP) and Mallinckrodt Announce Results from Pivotal Phase 3 Trial of CPP-1X/Sulindac in Patients with Familial Adenomatous Polyposis

Full data to be presented in detail by CPP at Digestive Disease Week (DDW) conference on May 19, 2019 at 5:19 pm Pacific Time

May 7, 2019
·
4 min read
Deals

Mallinckrodt plc Reports Strong Growth in First Quarter 2019 Results, Raises Guidance for 2019, and Continues to Make Significant Advancements in Pipeline and Data Generation

Net sales up 4.7%, or 5.0% on a constant-currency basis, on $790.6 million, led by strong performance of hospital products and the Specialty Generics and Amitiza segment

May 7, 2019
·
14 min read
BioForest

QuoteWizard Study Finds the Fittest and Fattest States in America

QuoteWizard®, a LendingTree company, and one of the nation’s leading online insurance marketplaces, conducted a study that found the fittest and fattest states in America.

May 7, 2019
·
3 min read
Deals

Evofem Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update

Management to Host Conference Call at 11:00 a.m. EDT

May 7, 2019
·
8 min read
Pharm Country

Legal-Bay Pre Settlement Funding Expects Delays in IVC Filter Settlements

Leading lawsuit funding company says Bard and Cook continue to contend liability.

May 7, 2019
·
2 min read
Pharm Country

PlaneAire™ Surface & Air Purifying Travel Mist Lands at CIBO Express Gourmet Markets™

The Plant-Based Antibacterial Mist Is Now on Sale at John F. Kennedy, LaGuardia and Newark Airports

May 7, 2019
·
3 min read
Biotech Beach

Direct Relief Donates $1.4 million to 11 Texas Free and Charitable Clinics for Hurricane Harvey Recovery and Resilience

Direct Relief announced it is providing $1.4 million in grants to 11 free health clinics in Southeast Texas, to help them recover from lingering damage from Hurricane Harvey, make them more resilient to future severe storms, and increase their capacity to serve patients.

May 7, 2019
·
4 min read
Drug Development

Clover Biopharmaceuticals Receives NMPA Approval for SCB-313 (TRAIL-Trimer) to Initiate Clinical Trials in China

A phase I clinical trial for malignant ascites is planned to initiate in China this year.

May 7, 2019
·
3 min read
Pharm Country

Advaxis to Participate in Five Upcoming Industry Conferences

Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces participation in five upcoming industry conferences:

May 7, 2019
·
5 min read
Job Trends

Functional Remedies Partners with Leading U.S. Chiropractic Supply Distributor

The Industry’s Only Whole-Plant, Lipid-Infused Hemp Oil Now Available via Wholesale to Licensed Chiropractors Through ScripHessco

May 7, 2019
·
3 min read